|
US4767619A
(en)
|
1981-09-14 |
1988-08-30 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government |
Burn wound dressing material
|
|
US4511563A
(en)
|
1983-07-15 |
1985-04-16 |
Basf Wyandotte Corporation |
Clear analgesic gels with reduced tackiness
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
DE3720147A1
(de)
|
1987-06-16 |
1988-12-29 |
Hoechst Ag |
Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
|
|
US5296504A
(en)
|
1988-09-06 |
1994-03-22 |
Kabi Pharmacia |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US4883660A
(en)
|
1988-10-17 |
1989-11-28 |
Thames Pharmacal Co., Inc. |
Gel bases for pharmaceutical compositions
|
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
|
DE4212105A1
(de)
|
1992-04-10 |
1993-10-14 |
Roehm Pharma Gmbh |
Nagellack zur Behandlung von Onychomykosen
|
|
US5352708A
(en)
|
1992-09-21 |
1994-10-04 |
Allergan, Inc. |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US6011062A
(en)
|
1994-12-22 |
2000-01-04 |
Alcon Laboratories, Inc. |
Storage-stable prostaglandin compositions
|
|
JP2001523273A
(ja)
|
1998-02-09 |
2001-11-20 |
マクロケム・コーポレーシヨン |
抗真菌性爪ラッカーおよびそれの使用方法
|
|
US6231875B1
(en)
|
1998-03-31 |
2001-05-15 |
Johnson & Johnson Consumer Companies, Inc. |
Acidified composition for topical treatment of nail and skin conditions
|
|
US7166730B2
(en)
|
2000-01-27 |
2007-01-23 |
Fine Tech Laboratories, Ltd |
Process for the preparation of prostaglandin derivatives
|
|
IL134241A
(en)
|
2000-01-27 |
2006-06-11 |
Finetech Pharmaceutical Ltd |
Process for the preparation of latanoprost
|
|
IL143477A
(en)
|
2001-05-31 |
2009-07-20 |
Finetech Pharmaceutical Ltd |
Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
|
|
WO2001057015A1
(en)
|
2000-02-01 |
2001-08-09 |
Cayman Chemical Company, Inc. |
INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION
|
|
US6495124B1
(en)
|
2000-02-14 |
2002-12-17 |
Macrochem Corporation |
Antifungal nail lacquer and method using same
|
|
US20020172693A1
(en)
*
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
|
MXPA04000473A
(es)
|
2001-07-17 |
2004-12-06 |
Pharmacia & Up John Company |
Procedimiento e intermediarios en la preparacion del latanoprost.
|
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
WO2003079997A2
(en)
|
2002-03-21 |
2003-10-02 |
Cayman Chemical Company |
Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma
|
|
US20030049307A1
(en)
|
2002-08-15 |
2003-03-13 |
Gyurik Robert J. |
Pharmaceutical composition
|
|
US7109371B2
(en)
|
2004-01-05 |
2006-09-19 |
Johnson Matthey Public Limited Company |
Prostaglandin synthesis
|
|
CN100469765C
(zh)
|
2004-01-05 |
2009-03-18 |
尼考斯股份公司 |
前列腺素硝基氧衍生物
|
|
EP1627610A1
(en)
*
|
2004-08-21 |
2006-02-22 |
TLT Medical Ltd |
Drug delivery throug application in nails
|
|
ES2418153T3
(es)
*
|
2006-03-08 |
2013-08-12 |
Cortria Corporation |
Terapia de combinación con inhibidores no selectivos de COX para prevenir lesiones gástricas relacionadas con COX
|
|
US7666912B2
(en)
*
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
|
IL177762A0
(en)
|
2006-08-29 |
2006-12-31 |
Arieh Gutman |
Bimatoprost crystalline form i
|
|
FR2920309B1
(fr)
|
2007-08-28 |
2010-05-28 |
Galderma Res & Dev |
Utilisation de travoprost pour traiter la chute des cheveux
|
|
WO2009103150A1
(en)
*
|
2008-02-20 |
2009-08-27 |
Kevin David Smith |
Method for treating migraine headaches
|
|
EP2127638A1
(en)
|
2008-05-30 |
2009-12-02 |
Santen Pharmaceutical Co., Ltd |
Method and composition for treating ocular hypertension and glaucoma
|
|
US20080275118A1
(en)
*
|
2008-06-12 |
2008-11-06 |
Shaw Mari M |
Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
|
|
EP2143712A1
(en)
|
2008-07-10 |
2010-01-13 |
Sandoz AG |
Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
|
|
US8722739B2
(en)
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
WO2010080915A1
(en)
|
2009-01-08 |
2010-07-15 |
Allergan, Inc. |
Compositions for enhancing nail growth
|
|
IT1393112B1
(it)
|
2009-02-27 |
2012-04-11 |
Sifavitor S R L |
Procedimento per la preparazione di derivati di prostaglandine
|
|
JP5734302B2
(ja)
|
2009-11-02 |
2015-06-17 |
上海天偉生物制薬有限公司 |
ビマトプロストの結晶およびその製造方法と用途
|
|
CN107982211A
(zh)
*
|
2011-04-05 |
2018-05-04 |
奥普托索夫研究与发展有限公司 |
眼科治疗
|
|
RU2014117580A
(ru)
*
|
2011-10-05 |
2015-11-10 |
Аллерган, Инк. |
Составы для улучшения здоровья ногтей
|
|
CA2935957C
(en)
*
|
2014-01-10 |
2023-01-03 |
Manistee Partners Llc |
Treatment of migraines using topical administration of prostaglandin f2alpha analogs
|